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Purpose: Halloysite nanotubes (HNTs) are a natural aluminosilicate clay with a chemical 
formula of Al2Si2O5(OH)4×nH2O and a hollow tubular structure. Due to their peculiar 
structure, HNTs can play an important role as a drug carrier system. Currently, the mechan-
ism by which HNTs are internalized into living cells, and what is the transport pathway, is 
still unclear. Therefore, this study aimed at establishing the in vitro mechanism by which 
halloysite nanotubes could be internalized, using phagocytic and non-phagocytic cell lines as 
models.
Methods: The HNT/CURBO hybrid system, where a fluorescent probe (CURBO) is con-
fined in the HNT lumen, has been used as a model to study the transport pathway mechan-
isms of HNTs. The cytocompatibility of HNT/CURBO on cell lines model was investigated 
by MTS assay. In order to identify the internalization pathway involved in the cellular 
uptake, we performed various endocytosis-inhibiting studies, and we used fluorescence 
microscopy to verify the nanomaterial internalization by cells. We evaluated the haemolytic 
effect of HNT/CURBO placed in contact with human red blood cells (HRBCs), by reading 
the absorbance value of the supernatant at 570 nm.
Results: The HNT/CURBO is highly biocompatible and does not have an appreciable 
haemolytic effect. The results of the inhibition tests have shown that the internalization 
process of nanotubes occurs in an energy-dependent manner in both the investigated cell 
lines, although they have different characteristics. In particular, in non-phagocytic cells, 
clathrin-dependent and independent endocytosis are involved. In phagocytic cells, in addition 
to phagocytosis and clathrin-dependent endocytosis, microtubules also participate in the 
halloysite cellular trafficking. Upon internalization by cells, HNT/CURBO is localized in 
the cytoplasmic area, particularly in the perinuclear region.
Conclusion: Understanding the cellular transport pathways of HNTs can help in the rational 
design of novel drug delivery systems and can be of great value for their applications in 
biotechnology.
Keywords: halloysite nanotubes, endocytic pathway, cellular internalization, 
biocompatibility, hemocompatibility
Introduction
Drug carrier systems based on nanomaterials have attracted a lot of attention over the 
past few years thanks to their great potential and the biocompatibility of biomaterials 
has gained great significance. In the study of biological responses to materials, evalua-
tion of cytotoxicity is the preliminary screening test used for almost all materials.1 
Halloysite is a two-layered aluminosilicate, with chemical composition similar to 
kaolinite, which has the following chemical formula (Al2Si2O5 (OH)4·nH2O)2,3 and 
a hollow tubular structure in the sub-micrometer range.4–7 Lately, pristine or 
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functionalized HNTs have obtained increasingly attention as 
drug delivery systems into cells. They have been reported to 
have a good biocompatibility and safety profile following the 
cellular internalization.8–12 Due to their properties, HNTs 
could be used for the encapsulation of drugs, biologically 
active molecules3,13–19 and as potential non-viral vector for 
oral gene therapy.12,20 Moreover, thanks to their large speci-
fic surface area, high biocompatibility and nanotubular struc-
ture, HNTs are used as support materials and for the loading 
and controlled release study of various substances.21–25
For example, understanding which pathways could be 
involved in the cellular uptake of this non-viral vector may 
help designing more effective gene carriers. Generally, 
nanoparticles internalization by cells is mainly dependent 
on size, surface charge and functionalization.26 Although it 
is known that halloysite nanotubes can pass through the 
plasma membrane and enter cells, the exact mechanism by 
which they are internalized in the cells is not yet well 
established.27 For further development of HNTs as a drug 
carrier system, it is essential to further investigate this topic, 
in order to better understand the specific mechanism by 
which they are internalized in living cells. Therefore, our 
aim in this work is to study the mechanisms involved in the 
cellular uptake of halloysite nanotubes by various endocy-
tosis-inhibiting studies and fluorescence microscopy. To this 
end, since nanotubes do not possess photo-luminescent 
properties, the hybrid system HNT/CURBO has been used, 
in which the fluorescent probe CURBO is supramolecularly 
loaded into the HNT lumen (Figure 1).28
The peculiarity of this hybrid system is that the fluores-
cent probe has a great affinity for the lumen, so is very similar 
to pristine halloysite nanotubes because the external surface 
does not have any type of functionalization. This allowed us 
to study the interaction with the plasma membrane, without 
any influence that could be given by the addition of func-
tional groups on the external surface. The focus of our study 
was on two cell types that have distinct barrier functions. In 
particular, different endocytic uptake mechanisms were 
investigated using a mouse macrophage cell line (Raw 
264.7) that is widely used as a model for primary 
macrophages,29 and a human epithelial cell line (HeLa) as 
models. The different characteristics of the two cell lines 
studied could involve distinct internalization pathways. The 
cell membrane is a thin semi-permeable membrane that 
protects all the intracellular components from the surround-
ing environment. The cell membrane is therefore involved in 
maintaining cell homeostasis, serves as structural support for 
the cell and helps maintaining its shape, maintaining ion 
concentration gradients and controlling the entry and exit of 
nutrients and small molecules.30–33 Entry through the cell 
membrane can occur by passive diffusion or through other 
mechanisms, for example channel, receptor, or 
transporter.34–36 Currently, several mechanisms have been 
identified by which nanoparticles enter inside the cells. 
Various endocytic processes enclose nanoparticles in mem-
brane vesicles in an energy-dependent manner. Mainly, endo-
cytosis can be classified into two categories: phagocytosis 
and pinocytosis. Phagocytosis is a relevant process that 
occurs in specialized cells as mononuclear phagocytes and 
neutrophils. Particle internalization consists mainly in the 
interaction, recognition and ingestion by a vesicle derived 
by plasmatic membrane called phagosome.37–39 Pinocytosis 
can be divided into micropinocytosis, clathrin-dependent 
(CDE) and clathrin-independent endocytosis (CIE).40,41 In 
order to identify the internalization pathway of the HNT/ 
CURBO, we used different drugs to selectively inhibit the 
various endocytic processes: Sodium azide (NaN3); 
Chlorpromazine hydrochloride; Cytochalasin D and 
Nocodazole. Sodium azide, is commonly used to deplete 
cellular ATP levels and to generally inhibit endocytosis or 
energy-dependent process.42–45 Chlorpromazine hydrochlor-
ide is used to inhibit CDE, it can inhibit clathrin-coated pit 
formation by a reversible translocation of clathrin and its 
adapter proteins from the plasma membrane to intracellular 
vesicles.41,46–48 Cytochalasin-D-induced depolymerization 
of f-actin,49 can be used to inhibit phagocytosis, and 
Figure 1 Hybrid system HNT/CURBO obtained by supramolecular inclusion with the fluorescent probe CURBO in the lumen of the tubes.
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clathrin/caveolin-independent endocytosis.50–54 Nocodazole 
is a pharmacological inhibitor for microtubule polymeriza-
tion, which is responsible for a variety of cell movements, 
including intracellular transport.55 Before proceeding with 
internalization studies, as these drugs can induce adverse 
effects, the cytotoxicity was tested by MTS assay in both 
cell lines used as model, examining cell respiration by mito-
chondrial dehydrogenase activity. The use of nanomaterials 
for applications in the biomedical field requires that these 
induce, upon contact with red blood cells (RBCs), 
a percentage of hemolysis that is less than or equal to 5%.1 
Blood compatibility is another important prerequisite for 
biomaterials, despite the cytocompatibility of HNTs has 
been widely considered, little is known about halloysite and 
hemocompatibility. Herein, we performed a hemocompat-
ibility test, to study the red blood cells stability when in 
contact with the HNT/CURBO. The hemolysis ratio of 
HNTs, CURBO and HNT/CURBO was tested in vitro on 
human red blood cells (HRBCs).
Materials and Methods
Materials
Cytochalasin D, Chlorpromazine H, Sodium azide and 
Nocodazole were obtained from Sigma-Aldrich. Fetal 
bovine serum (FBS), Roswell Park Memorial Institute 
(RPMI) 1640 medium, trypsin and penicillin-streptomycin 
were purchased by Gibco Life Technologies. Halloysite was 
purchased from Sigma-Aldrich by Merck and used without 
further purification. Halloysite has an average tube diameter 
of 50 nm and inner lumen diameter of 15 nm. Typical 
specific surface area is 65 m2 g−1; pore volume of 
~1.25 cm3 g−1; refractive index 1.54 and specific gravity 
2.53 g cm−3.
HNT/CURBO was synthetized as reported elsewhere.28
Cell Culture
Human cervical cancer cells (HeLa cells) were purchased 
by ATCC (American Type Culture Collection) and cul-
tured in Roswell Park Memorial Institute (RPMI) 1640 
medium supplemented with 5% Fetal Bovine Serum 
(FBS) and 2 mM L-glutamine, 100 units per mL penicillin 
and 100 mg/mL streptomycin and incubated in 
a humidified atmosphere at 37 °C in 5% CO2. Murine 
macrophage cells (Raw 264.7 cells) were purchased by 
ATCC and were maintained in RPMI medium supplemen-
ted with 10% FBS and 2 mM L-glutamine, 100 units 
per mL penicillin and 100 mg/mL streptomycin and 
incubated in a 5% CO2 humidified atmosphere at 37 °C in 
CO2 incubator.
Biocompatibility of HNT/CURBO on 
HeLa and Raw 264.7 Cells
HeLa and Raw 264.7 cells were seeded at a density of 1×104 
cells per well in a flat-bottom 96-well plate and incubated for 
24h at 37 °C in 5% CO2. Afterwards, cells were treated with 
different concentrations of HNT/CURBO ranging from 44 to 
176 µg/mL and incubated at 37 °C in 5% CO2 atmosphere for 
24h. After treatment, cell viability was assayed using 3-(4,5- 
dimethylthiazol-2-yl)-5-(3 carboxymethoxyphenyl)-2(4-sul-
fophenyl)-2H-tetrazolium (MTS), added to the cells and 
allowed to develop for 1h at 37 °C. Colorimetric measure-
ments were performed at 490 nm using an ELISA plate 
reader. The cell viability percentage was expressed by 
equation: Cell viability = (D sample/D control) x 100%; where 
D sample and D control are the absorbance of the sample and the 
control.
MTS Assay Chlorpromazine H, 
Cytochalasin D, Nocodazole and Sodium 
Azide
HeLa and Raw 264.7 cells were seeded at a density of 1×104 
cells per well on 96-well plates and incubated overnight at 
37 °C in 5% CO2. Afterwards, cells were treated with different 
concentrations of Cytochalasin D and Nocodazole ranging 
from 5 µM to 20 µM, Chlorpromazine Hydrochloride ranging 
from 5 to 10 µg/mL, and NaN3 0.05–0.005%. Cells were 
incubated at 37 °C in 5% CO2 atmosphere for 2h 30ʹ and 
24h. After treatment, cell viability was assayed using 3-(4,5- 
dimethylthiazol-2-yl)-5-(3 carboxymethoxyphenyl)-2(4-sulfo-
phenyl)-2H-tetrazolium (MTS), added to the cells and allowed 
to develop for 1h at 37 °C. Colorimetric measurements were 
performed at 490 nm using an ELISA plate reader.
Statistics MTS Assay
All experiments were performed in triplicate and repeated 
at least twice. The results were expressed as mean ± SEM. 
The responses were calculated as a percentage compared 
to the untreated group results.
Inhibition Studies and Distribution of 
HNT/CURBO in Living Cells
HeLa cells were seeded at a density of 2×104 cells per 
well on chamber slide for cell culturing and incubated 
for 24h at 37 °C in 5% CO2. Subsequently, cells were 
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treated for 2h 30ʹ with Chlorpromazine Hydrochloride 
(10 µg/mL), Cytochalasin D (10 µM) and Sodium 
azide 0.005%. Once finished the treatment, cells were 
washed with phosphate buffer saline 1X (PBS-1X) and 
then HNT/CURBO (88 µg/mL) was added for 24h. 
Raw 264.7 cells were seeded at a density of 2×104 
cells per well on chamber slide for cell culturing and 
incubated for 24h at 37 °C in 5% CO2. Subsequently, 
cells were treated for 2h 30ʹ with Chlorpromazine 
Hydrochloride (10 µg/mL), Cytochalasin D (10 µM), 
Nocodazole (10 µM) and Sodium azide 0.005%. Once 
finished the treatment, cells were washed with PBS-1X 
and then HNT/CURBO (88 µg/mL) was added for 4h. 
At the end, cells were washed with PBS-1X and fixed 
with 4% paraformaldehyde for 20 minutes. After this 
passage cells were washed with PBS-1X and nuclei 
were stained with 1 μg/mL of the nuclear stain 
Hoechst 33342 (Invitrogen) for 20 minutes. After 
nuclear staining, cells were further washed with PBS 
1X, and the slide was observed under fluorescence 
microscope.
Hemocompatibility
In order to evaluate the interaction of nanomaterials 
with human blood, we employed a procedure reported 
elsewhere with minor modifications.55 Fresh blood was 
collected from 12 healthy subjects (1:1 men/women). 
Five milliliters of blood were centrifuged (1000×g 20 
minutes) and washed with PBS-1X pH 7.4 (10 mL) 
three times, according to completely remove serum 
and obtain human red blood cells (HRBCs). After 
that, the HRBCs were diluted with PBS 1X pH 7.4 
solution (1:5). Then, 0.25 mL of the diluted HRBCs 
suspension was transferred to a 1.5 mL Eppendorf 
tube, which was filled with 0.5 mL of water (as posi-
tive control), PBS 1X buffer (as negative control), and 
different concentration of HNT (10, 20, 50, 100, 200 
µg/mL), HNT/CURBO (10, 20, 50, 100, 200 µg/mL), 
CURBO (1.08, 2.16, 5.4,10.8, 21.6 µM) and acetoni-
trile as further control (solvent of CURBO). All the 
samples were incubated at 37 °C for 12h then centri-
fuged at 1000×g 4 °C for 20 minutes. The absorbance 
at 570 nm of supernatant liquid was measured with 
microplate reader. Written informed consent was 
obtained from each subject. The hemolysis rate was 
calculated as follows:
Hemolysis
ratio %ð Þ ¼
Sample absorbance   Negative control
Positive control   Negative control
� 100%
Results
Biocompatibility of HNT/CURBO on 
HeLa and Raw 264.7 Cells
Considering that low cytotoxicity is one of the essential 
properties of an ideal carrier system, the in vitro effects of 
the HNT/CURBO hybrid on HeLa and Raw 264.7 cells 
were investigated by MTS assay prior to internalization 
studies. The cell viability was examined upon exposure to 
different concentrations of HNT/CURBO as depicted in 
Figure 2 for 24h, 48h and 72h. The results reveal that this 
new nanomaterial, as raw HNT, exhibits low cytotoxicity; 
viability is almost 80% for the highest concentration of 
HNT/CURBO in HeLa cells and close to 100% in Raw 
264.7 following a 24h incubation (Figure 2A). Even after 
treatments of 48h (Figure 2B) and 72h (Figure 2C), cell 
viability remained high for both cell lines. As regards Raw 
264.7 macrophages, cell viability values exceeding 100%, 
demonstrating that HNT/CURBO is not toxic to cells and 
highly biocompatible. The HNT/CURBO nanomaterial 
was synthesized by following a procedure previously 
reported. Briefly, the biocompatible probe was obtained 
by the loading of CURBO molecules into pristine HNT 
by vacuum cycling of an HNT suspension in a MeCN 
solution of CURBO. Following this procedure, 
the percent loading of the CURBO into HNT lumen, 
estimated by thermogravimetric analysis, was ca. 4 wt%. 
The physicochemical characterization highlighted the suc-
cessful loading of CURBO into HNTs. FT-IR spectroscopy 
indeed showed the presence of CURBO characteristic 
vibration bands in the HNT/CURBO spectrum. The pre-
sence of the organic moieties into the lumen was esteemed 
by morphological studies and by DLS measurements. We 
estimated a hydrodynamic radius of ca. 340 nm, highlight-
ing the absence of the formation of clusters between the 
modified nanotubes. Furthermore, solid-state fluorescent 
measurements showed that the HNT/CURBO emits in 
both green and red while excited in the blue portion of 
the electromagnetic spectrum. In order to evaluate the 
internalization pathway of HNT/CURBO, it is also essen-
tial to estimate the cellular toxicity of each of the pharma-
cological inhibitors. To this end, the cell viability was 
investigated upon exposure to different concentrations of 
Cytochalasin D, Chlorpromazine H, Nocodazole and 
Sodium azide for 2h 30ʹ (Figures 3A and 4A). It is 
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known in the literature that to establish an optimal proto-
col for their use, it is necessary to evaluate the in vitro 
cellular toxicity because treatments for prolonged periods 
of time turn out to be toxic to cells.47 As it is possible to 
observe, as a result of the treatment with inhibitor drugs, 
there is an alteration in cell morphology, but despite this, 
MTS assay confirms that cells are still viable (except for 
the highest concentration of Chlorpromazine H). In addi-
tion, to assess cell viability, cells were also observed under 
microscope to evaluate possible changes in morphology in 
response to treatment with these drugs (Figures 3B and 
4B). Chlorpromazine H (10 µg/mL), Sodium azide 
Figure 2 Cell viability assay on HeLa and Raw 264.7 cells. Cells were treated with different concentrations of HNT/CURBO, HNT, and CURBO for 24h (A), 48h (B) and 
72h (C).
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Figure 3 (A) Cell viability assay performed on HeLa cells after treatment of 2h 30ʹ with different concentrations of inhibitory drugs Chlorpromazine H, Cytochalasin D, 
Nocodazole and Sodium Azide. (B) Microscope images of HeLa cells following the treatment of 2h 30ʹ with the different concentrations of the inhibitory drugs.
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Figure 4 (A) Cell viability assay performed on Raw 264.7 cells after treatment of 2h 30ʹ with different concentrations of inhibitory drugs Chlorpromazine H, Cytochalasin D, 
Nocodazole and Sodium Azide. (B) Microscope images of Raw 264.7 cells following the treatment of 2h 30ʹ with the different concentrations of the inhibitory drugs.
International Journal of Nanomedicine 2021:16                                                                                   https://doi.org/10.2147/IJN.S303816                                                                                                                                                                                                                       
DovePress                                                                                                                       
4761
Dovepress                                                                                                                                                          Biddeci et al



































































0.005%, Cytochalasin D and Nocodazole (10 µM) were 
the optimal concentration of drugs to use for inhibition 
studies.
Inhibition Studies and Distribution of 
HNT/CURBO in Living Cells
Before analyzing the possible pathway involved in HNTs 
cellular uptake, live HeLa and Raw 264.7 cells were 
incubated with HNT/CURBO and were observed under 
fluorescence microscope to verify the nanomaterial inter-
nalization by cells. HeLa cells were treated for 24h with 
different concentrations of HNT/CURBO, while Raw 
264.7 cells were subjected to a 4h treatment. Indeed, it 
is known in literature that macrophages are able to 
degrade halloysite.56 The green fluorescence signal can 
be clearly seen inside both cell lines (Figure 5A and B) 
by fluorescence microscopy. Green fluorescent signals 
inside the cells indicate that the compound can be inter-
nalized and that is localized in the cytoplasmic area, 
particularly in the perinuclear region. In Figure 6 we 
show that HeLa cells are treated for 24h with HNT/ 
CURBO (88 µg/mL) after pre-treatment of 2h 30ʹ with 
different inhibitors. As it is possible to observe, in HeLa 
cells pre-treated with Sodium azide (Figure 6D), 
Cytochalasin D (Figure 6E) and Chlorpromazine 
H (Figure 6F), there is a considerable reduction in FITC 
signal inside cells, related to a decrease inside the cells of 
HNT/CURBO compared to the condition where cells are 
not treated with inhibitors (Figure 6C). In Figure 6B, 
control cells were treated with unlabeled HNTs, no fluor-
escence signals can be detected. Also, in Raw 264.7 cells 
(Figure 7) pre-treated with Sodium azide (Figure 7D), 
Cytochalasin D (Figure 7E), Chlorpromazine 
H (Figure 7F), and Nocodazole there is a decrease in 
FITC signal, due to the presence of HNT/CURBO inside 
the cells, compared to the condition where cells are not 
treated with inhibitors (Figure 7C). In Figure 7B, Raw 
264.7 were treated only with unlabeled HNTs, and as 
shown, no fluorescence signals can be detected. To ana-
lyze the number of internalized nanoparticles under the 
different conditions, we used the “ImageJ” software, 
which allowed us to analyze the fluorescence given by 
HNT/CURBO inside the cells following treatment with 
the different drugs Sodium azide, Cytochalasin D, 
Chlorpromazine H and Nocodazole, compared to the 
control. We analyzed a different number of fields (n=6) 
for each condition, the columns marked with (*) in 
Figure 8 indicate that there is a significant statistical 
difference (p < 0.01) in fluorescence between cells with-
out treatment and those treated with the different inhibi-
tors. The result for Hela cells (Figure 8A) shows that 
HNT/CURBO is internalized into cells by energy- 
dependent manner. In fact, when cells are treated with 
Sodium azide 0.005% there is a significant reduction of 
HNT/CURBO internalization. It is also evident that 
Chlorpromazine hydrochloride and Cytochalasin D are 
able to greatly inhibit clathrin-mediated endocytosis and 
clathrin/caveolin-independent endocytosis, respectively. 
Even in Raw 264.7 cells (Figure 8B), HNT/CURBO 
internalization is primarily dependent by energy (condi-
tion with Sodium azide). Even the presence of other 
inhibitors reduces the cellular uptake of HNT/CURBO. 
In particular, in this cell line also, Nocodazole reduces 
the cellular uptake of HNT/CURBO, indicating that 
microtubules also participate in the cellular trafficking 
of this nanomaterial. We can therefore conclude that in 
macrophage cells, HNT/CURBO internalization depends 
on clathrin-mediated endocytosis and phagocytosis.
Hemocompatibility
As regard the nanomaterials for applications in the biome-
dical field, it is important to verify their haemolytic potency 
when contacting the blood. In this study, we investigate the 
effects on Human Red Blood Cells (HRBCs) exposed to 
pristine halloysite and HNT/CURBO for 24h at 37 °C. After 
exposure to different concentrations (Figure 9), a non- 
noticeable haemolytic event can be observed, except for 
the positive control (water). To quantify the hemolytic effect 
of each concentration of HNT and HNT/CURBO on 
HRBCs, absorbance of the supernatant at 570 was measured. 
This provides us with an indication of a possible red blood 
cells membrane damage. Looking at the results, it is evident 
that there is a significant difference in the absorbance at 570 
nm, associated with red blood cells (RBCs) membrane 
damage and release of haemoglobin, between the positive 
control (RBCs exposed to water) and condition treated with 
different concentrations of HNT – HNT/CURBO. The 
hemolysis percentage values induced by exposition of 
HRBCs to different concentrations of HNT/CURBO 
(Figure 9B) were all less than 5%. This result suggests that 
the nanomaterial does not exhibit a significant haemolytic 
effect, also in relation to pristine HNT (Table 1), conforming 
to the national biological material hemolysis rate security 
specified requirements.
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The mechanism by which HNTs are internalized could be 
dependent, not only on the properties of HNTs but also on 
the phagocytic nature of cells. Since surface charge could 
affect the ability of internalization and the uptake mechan-
isms, ζζpotential of HNT/CURBO was measured after 
Halloysite modification and it turned out to be still 
negative. Furthermore, the release of the fluorescent 
probe from the lumen of the tube is very slow. The study 
of release kinetics of CURBO from the lumen of the 
nanotubes, at different time intervals in phosphate- 
buffered saline (PBS) at pH 7.4, revealed that after about 
8h the release percentage is equal to 4.6% and that this 
remains constant after 24h.28 Therefore, the HNT/CURBO 
Figure 5 Fluorescence microscopy images. (A) HeLa cells treated for 24h with HNT/CURBO at a final concentration of 88 µg/mL. Scale bar: 10 µm, magnification 20x (B) 
Raw 264.7 cells treated for 4h with HNT/CURBO at a final concentration of 88 µg/mL. The nuclei are highlighted in blue (DAPI), and HNT/CURBO in green (FITC) which is 
localized in the perinuclear region. Scale bar: 5 µm, magnification 20x.
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could be used as an efficient imaging agent for biological 
purposes. Furthermore, due to the localization of the fluor-
escent probe into the HNT lumen, the developed system 
can be similar to pristine HNT since its external surface is 
unmodified. The latter could be crucial to investigate the 
halloysite uptake mechanism. With this idea in mind, both 
Figure 6 Inhibition of HNT/CURBO internalization in HeLa cells. (A) Untreated HeLa cells; (B) HeLa cells treated for 24h with pristine HNT (88 µg/mL); (C) HeLa cells 
treated for 24h with HNT/CURBO (88 µg/mL); HeLa cells treated with: (D) Sodium azide (0.005%); (E) Cytochalasin D (10 µM); (F) Chlorpromazine H (10 µg/mL) for 2h 
30ʹ and then with HNT/CURBO (88 µg/mL) for 24h. The nuclei are highlighted in blue (DAPI), and HNT/CURBO in green (FITC), which is localized in the perinuclear 
region. Scale bar: 10 µm, magnification 20x.
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Figure 7 Inhibition of HNT/CURBO internalization in Raw 264.7 cells. (A) Untreated Raw 264.7 cells; (B) Raw 264.7 cells treated for 4 h with pristine HNT (88 µg/mL); 
(C) Raw 264.7 cells treated for 4h with HNT/CURBO (88 µg/mL); Raw 264.7 cells treated with: (D) Sodium azide (0.005%); (E) Cytochalasin D (10 µM); (F) 
Chlorpromazine H (10 µg/mL); (G) Nocodazole (10 µM) for 2h 30ʹ and then with HNT/CURBO (88 µg/mL) for 4h. The nuclei are highlighted in blue (DAPI), and 
HNT/CURBO in green (FITC), which is localized in the perinuclear region. Scale bar: 5 µm, magnification 20x.
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non-phagocytic and phagocytic cells were used as models. 
In particular, we chose HeLa cells (human epithelial ade-
nocarcinoma cell line) and Raw 264.7 (murine macro-
phage cell line) cells which are often used as a model for 
primary macrophages.29 As regard the nanomaterials for 
applications in biomedical field, it is important to verify 
their biocompatibility and their hemolytic potency when in 
contact with blood. MTS assay demonstrated that HNT/ 
CURBO is not cytotoxic and that is highly biocompatible 
for both cell lines. In addition, the nanomaterial does not 
exhibit an appreciable haemolytic effect. Based on the 
information obtained by fluorescence microscopy, it is 
clear that the HNT/CURBO hybrid system can enter in 
the cytoplasm of living cells. The transport process of the 
hybrid starts probably with a cell membrane interaction 
and continues in energy-dependent internalization in both 
cell lines. In particular, in HeLa cells, clathrin-dependent 
and independent endocytosis are involved. In Raw 264.7 
cells, in addition to phagocytosis and clathrin-dependent 
endocytosis, microtubules also participate in the cellular 
trafficking of HNT/CURBO. We can therefore say that 
there is a combination of several endocytic mechanisms 
Figure 8 Quantitative analysis of cellular uptake of HNT/CURBO in the presence of various inhibitors in HeLa (A) and Raw 264.7 (B) cells. The column marked with * (p< 
0.01) indicates that there is a significant statistical difference in fluorescence signal between treated and untreated cells.
Figure 9 In vitro hemocompatibility assay of (A) raw HNT and (B) HNT/CURBO after incubation at 37 °C for 12h. The positive control is in ultrapure water (100% lysis), 
and negative control is in PBS 1X (0% lysis).
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involved in the uptake of HNT/CURBO in both the epithe-
lial cells and macrophages. The relatively wide range of 
sizes for HNTs may be the reason why the internalization 
of HNTs is mediated by more than one cellular uptake 
pathways.57,58
Conclusion
Understanding the cellular transport pathways of HNTs 
may help in the rational design of novel drug delivery 
systems and may be of great value for their applications 
in biotechnology. Thanks to the high biocompatibility, 
HNT/CURBO could be a valuable system for drug deliv-
ery and future applications in the biomedical field. The 
predominantly perinuclear localization, as a result of cel-
lular internalization, leads us to believe that halloysite 
nanotubes could be excellent allies for intracellular drug 
delivery.
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